All In Biotech

Drug Trial Radar · NCT06260722

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Semaglutide Once Weekly in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Last checked: Nov 20, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 1,250 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,250

Planned (sponsor's estimate)

Start

Feb 21, 2024

Primary completion

Aug 27, 2026

Study completion Feb 2027

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Feb 15, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with semaglutide in participants with Type 2 Diabetes and inadequate glycemic control with metformin with or without sodium-glucose cotransporter-2 inhibitor (SGLT2i). The study will last about 26 months and may include up to 24 visits.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

  • RetatrutideDrug

    Administered SC.

  • SemaglutideDrug

    Administered SC.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Hemoglobin A1c (HbA1c) (%)Time frame: Baseline, Week 80

Locations

77 sites in 5 countries. Site status is shown where the registry gives one.

  • University of Alabama - Department of Nutrition Sciences

    Birmingham, Alabama

  • Neighborhood Healthcare Institute of Health

    Escondido, California

  • Long Beach Research Institute

    Long Beach, California

  • Valley Clinical Trials, Inc.

    Northridge, California

  • Rancho Cucamonga Clinical Research

    Rancho Cucamonga, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • Arrow Clinical Trials

    Daytona Beach, Florida

  • New Age Medical Research Corporation

    Miami, Florida

  • South Broward Research

    Miramar, Florida

  • Clinical Research of Central Florida

    Winter Haven, Florida

  • Herman Clinical Research

    Suwanee, Georgia

  • North Georgia Clinical Research

    Woodstock, Georgia

  • Pacific Diabetes & Endocrine Center

    Honolulu, Hawaii

  • Rocky Mountain Clinical Research

    Idaho Falls, Idaho

  • Deaconess Clinic - Gateway Health Center

    Newburgh, Indiana

  • IMA Clinical Research Monroe - Armand

    Monroe, Louisiana

  • MedStar Health Research Institute (MedStar Physician Based Research Network)

    Hyattsville, Maryland

  • Brigham and Women's Hospital Diabetes Program

    Boston, Massachusetts

  • NECCR PrimaCare Research

    Fall River, Massachusetts

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

    Troy, Michigan

  • Palm Research Center Tenaya

    Las Vegas, Nevada

  • Palm Research Center Sunset

    Las Vegas, Nevada

  • NYC Research INC

    Long Island City, New York

  • Medication Management

    Greensboro, North Carolina

  • Remington Davis Clinical Research

    Columbus, Ohio

  • Alliance for Multispecialty Research, LLC

    Norman, Oklahoma

  • Central States Research

    Tulsa, Oklahoma

  • The Corvallis Clinic, P.C.

    Corvallis, Oregon

  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania

  • Velocity Clinical Research, Dallas

    Dallas, Texas

  • Valley Institute of Research - Fort Worth

    Fort Worth, Texas

  • Juno Research

    Houston, Texas

  • Southern Endocrinology Associates

    Mesquite, Texas

  • Consano Clinical Research, LLC

    Shavano Park, Texas

  • Texas Valley Clinical Research

    Weslaco, Texas

  • Medrasa Clinical Research

    Wylie, Texas

  • Central Washington Health Services Association d/b/a Confluence Health

    Wenatchee, Washington

  • IMA Clinical Research West Virginia

    Morgantown, West Virginia

  • Centro de Investigaciones Metabólicas (CINME)

    Buenos Aires, Argentina

  • Fundación Respirar

    Buenos Aires, Argentina

Showing 40 of 77 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.